EWM Training for Attention Deficit Hyperactivity Disorder (ADHD)

1
Effectiveness
1
Safety
Institute of Living/Hartford Hospital, Hartford, CT
EWM Training - Behavioral
Eligibility
< 65
All Sexes
Eligible conditions
Attention Deficit Hyperactivity Disorder (ADHD)

Study Summary

This study is evaluating whether a novel executive working memory training intervention for Attention-Deficit/Hyperactivity Disorder can engage frontoparietal brain network treatment targets and behavioral performance. original

See full description

Treatment Effectiveness

Effectiveness Estimate

1 of 3

Study Objectives

This trial is evaluating whether EWM Training will improve 2 primary outcomes in patients with Attention Deficit Hyperactivity Disorder (ADHD). Measurement will happen over the course of Change in fMRI measurements from baseline assessment versus 5 weeks at the conclusion of training.

Week 5
Magnetic Resonance Imaging Functional Brain Scan using a Seimens 3T Skyra.
Week 5
The experimental executive working memory training tasks

Trial Safety

Trial Design

2 Treatment Groups

ADHD Placebo
ADHD EWM
Placebo group

This trial requires 62 total participants across 2 different treatment groups

This trial involves 2 different treatments. EWM Training is the primary treatment being studied. Participants will all receive the same treatment. Some patients will receive a placebo treatment. The treatments being tested are not being studied for commercial purposes.

ADHD EWM
Behavioral
Participants will receive EWM training sessions.
ADHD Placebo
Behavioral
Participants will receive placebo training sessions.

Trial Logistics

Trial Timeline

Approximate Timeline
Screening: ~3 weeks
Treatment: Varies
Reporting: change in scores from baseline assessment versus 5 weeks at the conclusion of training
This trial has the following approximate timeline: 3 weeks for initial screening, variable treatment timelines, and roughly change in scores from baseline assessment versus 5 weeks at the conclusion of training for reporting.

Who is running the study

Principal Investigator
M. S.
Michael Stevens, Senior Research Scientist
Hartford Hospital

Closest Location

Institute of Living/Hartford Hospital - Hartford, CT

Eligibility Criteria

This trial is for patients born any sex aged 65 and younger. There are 5 eligibility criteria to participate in this trial as listed below.

Mark “yes” if the following statements are true for you:
Diagnosis of ADHD
English speaking
Right-handed
>5th grade reading level
>80 IQ level

Patient Q&A Section

Please Note: These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

What are the signs of attention deficit hyperactivity disorder (adhd)?

Add answer

In a recent study, findings's findings provide new information about the symptoms of ADHD and its subtypes. There was no difference between the clinical and control groups in the scores of the three subtypes evaluated.

Unverified Answer

What are common treatments for attention deficit hyperactivity disorder (adhd)?

Add answer

There is considerable evidence for the use of CBT with regard to reduction in ADHD symptoms. The use of this technique may also be of clinical significance for enhancing learning/concrete skills by applying CBT to the learning situation.

Unverified Answer

How serious can attention deficit hyperactivity disorder (adhd) be?

Add answer

The impact of ADHD is significant as it leads to high-level deficits in domains of functioning and employment, although its comorbid diagnoses were not significantly correlated with ADHD severity.

Unverified Answer

What causes attention deficit hyperactivity disorder (adhd)?

Add answer

There are many reasons for ADHD, but a lack of effective support programs and medical treatment contributes to the high number of untreated patients with ADHD.

Unverified Answer

How many people get attention deficit hyperactivity disorder (adhd) a year in the United States?

Add answer

At least 25 million children under the age of 18 are diagnosed with at least one symptom of ADHD each year. The prevalence of ADHD increases with age.

Unverified Answer

What is attention deficit hyperactivity disorder (adhd)?

Add answer

Attention deficit hyperactivity disorder (adhd) is a condition with complex symptoms characterized by inattention, hyperactivity and impulsivity. Although less than 1% of the US population had an ADHD diagnosis in the past year, an estimated 15% of children and adolescents have this common disorder. Attention deficit hyperactivity disorder (adhd) is a comorbid condition with other mental disorders such as major depressive disorder, anxiety disorder and other somatoform disorders.

Unverified Answer

Can attention deficit hyperactivity disorder (adhd) be cured?

Add answer

Results of the present study suggest that ADHD and ODD can be treated to an acceptable level, although residual psychopathology may persist. Further research is indicated to increase knowledge of the persistence of residual psychopathology in treatment responders.

Unverified Answer

Is ewm training typically used in combination with any other treatments?

Add answer

The majority of children received combination treatment. The use of eWM training as part of a broader treatment program may have provided a more efficacious and sustained treatment paradigm.

Unverified Answer

What are the common side effects of ewm training?

Add answer

While ewm is effective in reducing some of the side effects associated with stimulant drugs, it does not appear to reduce the overall risk-taking for students. However, further studies are warranted to assess the risk of ewm and stimulant drugs in a larger sample size.

Unverified Answer

What is ewm training?

Add answer

While not a treatment option, it can improve specific cognitive function deficits. It offers a unique treatment methodology to remediate cognitive deficits associated with ADHD.

Unverified Answer

Does attention deficit hyperactivity disorder (adhd) run in families?

Add answer

The family history of ADD in some young persons with ADHD is not a function of an identifiable genetic or environmental risk factor for disease. Results from a recent paper suggest the possibility of alternative etiologic mechanisms, even in an at-risk population.

Unverified Answer

Have there been other clinical trials involving ewm training?

Add answer

Only one ewm, AHA/BCAA, trial has been published, with no evidence for its effects. The other studies have been published in medical journal, and involve many different study designs that are difficult to compare. Although further well-designed, appropriately powered, and adequately reported studies would be helpful, we believe there is no compelling evidence that ewm training is a useful and cost-effective intervention for adult ADHD.

Unverified Answer
See if you qualify for this trial
Get access to this novel treatment for Attention Deficit Hyperactivity Disorder (ADHD) by sharing your contact details with the study coordinator.